SYLMAR, Calif.--(BUSINESS WIRE)--Jun 11, 2025--
IEE, manufacturer of field-proven military displays, is moving into the production phase of a contract with L3Harris to deliver hundreds of 3ATI Electric Warfare (EW) Multi-Function Displays (MFDs) following the recent first-flight success of the Viper Shield digital electronic warfare system in the single-seat F-16 Block 70. As the cockpit display portion of a multi-LRU EW System (EWS), IEE’s 3ATI is a critical part of the Viper Shield system.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250611403519/en/
The full-color 3ATI is a smart display that presents threat data as well as diagnostic functions for the EWS. It also functions as the aircrew controller of the EWS. Through six system control buttons, the unit provides controls to start built-in test, prioritize threats, change modes, and mute audio. It can also give selective menus to regulate and change mission characteristics of the EWS. It features a two-position brightness control button to regulate the screen brightness from NVIS through daylight readable luminance.
“IEE has been working with L3Harris on this game changing technology for several years, and we continue to support the development and production of this 3ATI for the all-digital electronic warfare suite,” said Steve Motter, VP of Business Development. “We congratulate the Viper Shield team for a successful first flight and are happy to have entered the production phase of this exciting project.”
IEE’s 3ATI is customizable to size, resolution, interface and bezel design.
Product Features and Specifications
About IEE:
For over 75 years, IEE has been a trusted provider of enhanced displays for military and industrial applications. From rapid prototyping of custom designs to full-scale production runs, IEE’s factory in Sylmar, CA produces innovative displays with advanced features like low-latency video processing, high-bright and NVIS backlighting, and lightweight, ruggedized enclosures. IEE’s direct control of critical process steps reduces costs, decreases production lead times and improves lifecycle management. IEE display products are distributed worldwide. IEE is ISO 9001:2015 and AS9100D certified. For more information: visit ieeinc.com
Get our updates: http://www.linkedin.com/company/industrial-electronic-engineers
Follow us at: http://x.com/IEEdisplays
Become a fan: https://www.facebook.com/IEEdisplays
IEE 3ATI EW-MFD
LONDON (AP) — King Charles III has been “deeply touched” by the response to his update on his cancer treatment, Buckingham Palace said Saturday, adding that the monarch is pleased to have highlighted the value of screening programs for the disease.
Medics and health charities have praised the king for his openness, saying his statement on Friday had already prompted people to seek information about cancer.
In a strikingly personal video statement, the British monarch acknowledged that a cancer diagnosis can feel “overwhelming,” but said catching the disease early brings “the precious gift of hope.”
Here’s what to know about the king's condition and his message.
The 77-year-old king said in a statement broadcast Friday that his treatment schedule will be reduced in the new year, “thanks to early diagnosis, effective intervention and adherence to ‘doctors’ orders.’”
He encouraged others to take advantage of screening programs such as those for breast, bowel and cervical cancer offered by Britain’s public health service.
“Early diagnosis quite simply saves lives,” the king said in the statement aired during a “Stand Up to Cancer” telethon on TV station Channel 4. He said catching the disease early had allowed him “to continue leading a full and active life even while undergoing treatment.”
Charles has received outpatient treatment for almost two years. Buckingham Palace did not say the king is in remission, but that his treatment is moving to a “precautionary phase” and his condition will be monitored to ensure his continued recovery.
“I know from my own experience that a cancer diagnosis can feel overwhelming,” the king said in his video statement. “Yet I also know that early detection is the key that can transform treatment journeys, giving invaluable time to medical teams – and, to their patients, the precious gift of hope.”
Charles announced in February 2024 that he had been diagnosed with cancer, and, in a break from centuries of secrecy about royal health, he has since spoken about the illness, using his story to promote cancer awareness and treatment.
The openness has limits, though. The king has not disclosed what type of cancer he has or what kind of treatment he is receiving. The palace said it was an intentional decision designed to ensure his message reaches the widest possible audience.
The king’s cancer was discovered after treatment for an enlarged prostate. While doctors ruled out prostate cancer, tests revealed “a separate issue of concern,” palace officials said last year.
Charles suspended his public appearances for about two months after his diagnosis. Since returning to the public eye, he has visited cancer treatment centers across the country and shared stories with fellow patients.
Buckingham Palace said Charles “will be greatly encouraged and deeply touched by the very positive reaction" his message has generated. “He will be particularly pleased at the way it has helped to shine a light on the benefits of cancer screening programs,” it added.
British cancer charities said the number of people seeking information about cancer jumped after the king revealed he was undergoing treatment last year.
Cancer Research U.K. said about 100,000 people have visited its Screening Checker website since it was launched on Dec. 5, most of them since the king’s statement on Friday.
The charity's Chief Executive Michelle Mitchell said: “When public figures speak openly about their cancer diagnosis, it can prompt others to check in on their health.”
Broadcaster Jonathan Dimbleby, the king’s authorized biographer, said the statement was “a remarkable thing for a monarch to do.”
“It takes guts, and the fact that he came out and did that will save lives,’” Dimbleby said.
The Princess of Wales, who announced her own cancer diagnosis six weeks after her father-in-law, has also given updates on her treatment. Kate announced in January that her cancer is in remission.
Find more of AP’s coverage at https://apnews.com/hub/royalty
Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)
Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)
